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Observation of an unexpected third receptor molecule in the
crystal structure of human interferon-γ receptor complex
DJ Thiel1, M-H le Du1†, RL Walter1‡, A D’Arcy2, C Chène2, M Fountoulakis2,
G Garotta2§, FK Winkler2 and SE Ealick3*
Background: Molecular interactions among cytokines and cytokine receptors
form the basis of many cell-signaling pathways relevant to immune function.
Interferon-γ (IFN-γ) signals through a multimeric receptor complex consisting
of two different but structurally related transmembrane chains: the high-affinity
receptor-binding subunit (IFN-γRα) and a species-specific accessory factor (AF-1
or IFN-γRβ). In the signaling complex, the two receptors probably interact with one
another through their extracellular domains. Understanding the atomic interactions
of signaling complexes enhances the ability to control and alter cell signaling and
also provides a greater understanding of basic biochemical processes.
Results: The crystal structure of the complex of human IFN-γ with the soluble,
glycosylated extracellular part of IFN-γRα has been determined at 2.9 Å
resolution using multiwavelength anomalous diffraction methods. In addition to
the expected 2:1 complex, the crystal structure reveals the presence of a third
receptor molecule not directly associated with the IFN-γ dimer. Two distinct
intermolecular contacts, involving the edge strands of the C-terminal domains,
are observed between this extra receptor and the 2:1 receptor–ligand complex
thereby forming a 3:1 complex.
Conclusions: The observed interactions in the 2:1 complex of the high-affinity
cell-surface receptor with the IFN-γ cytokine are similar to those seen in a
previously reported structure where the receptor chains were not glycosylated.
The formation of β-sheet packing interactions between pairs of IFN-γRα
receptors in these crystals suggests a possible model for receptor
oligomerization of Rα and the structurally homologous Rβ receptors in the fully
active IFN-γ signaling complex.
Introduction
Receptor oligomerization is necessary in the signaling cas-
cades of nearly all known members of the cytokine receptor
superfamily. This superfamily is composed of two subdivi-
sions, the class 1 and the class 2 cytokine receptors, which
share a molecular architecture consisting of a ligand-
binding extracellular domain, a single transmembrane region
and a cytoplasmic domain [1]. Members of the class 1 sub-
division include the growth hormone (GH) receptor, the
prolactin receptor, the erythropoietin receptor, the granu-
locyte and granulocyte/macrophage colony-stimulating
factor receptors, receptors for various interleukins, and the
receptor for ciliary neurotrophic factor. Members of the
class 2 subdivision include the two interferon-γ (IFN-γ)
receptor chains (Rα and Rβ), the two chains of the IFN-α/β
receptor, the interleukin-10 receptor, tissue factor, and the
receptor-like molecule CRF2–4. The distinction between
the two cytokine receptor classes is made on the basis of
differences within the extracellular domains. Class 2
receptors lack the sequence WSXWS (in single-letter
amino acid code) found in the C-terminal domain of the
extracellular portion of class 1 receptors. In addition, two
pairs of conserved cysteine residues absent in the class 1
receptors are found in the extracellular domains of class 2
cytokine receptors [1]. In the case of IFN-γ, the high-
affinity cell-surface receptor α chain, IFN-γRα, is known
to initiate the signal transduction pathway by binding the
IFN-γ homodimer (Kd = 10–10 M) with a 2:1 stoichiometry
[2]. A second cell-surface receptor, the species-specific β
chain IFN-γRβ, also referred to as accessory factor 1 (AF-1),
is known to associate with the 2:1 complex to form the
active signaling complex with a 2:2:1 stoichiometry [2,3].
In the cytokine signaling pathways, initial receptor
oligomerization occurs upon the binding of the signaling
ligand to the extracellular domain of the receptor molecule
specific to that cytokine. Further oligomerization of addi-
tional species-specific receptors is essential in the case of
IFN-γ and other receptors. Because the intracellular regions
of these receptor molecules lack any common structural
motif, the extracellular regions are probably involved in the
mechanism of receptor oligomerization in addition to the
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binding of the ligand. On the basis of sequence analysis of
the known members of the cytokine receptor superfamily,
it was proposed that all members of this superfamily
exhibit a tandem set of fibronectin type-III domains within
their extracellular domains [1]. Because fibronectin type-
III structures are typically found in cell-surface molecules
with adhesive functions, this finding established a link
between cytokine receptors and cell adhesive molecules.
In light of this link, investigations of receptor–receptor
interactions of the superfamily are likely to provide addi-
tional understanding of signal transduction by elucidating
the mechanisms and roles of receptor oligomerization.
Crystal structure data depicting the generally weak recep-
tor–receptor interactions in atomic detail are limited.
Recently, ligand-induced, receptor–receptor dimeric inter-
actions have been suggested as relevant in the mediation
of signal transduction in T cells [4]. The soluble portion of
human CD4 (sCD4), a receptor molecule with structural
similarity to the cytokine receptor family, was found to
form dimers when crystallized in the absence of glycosyla-
tion. The dimerization was suggested to play a role in
signal transduction during antigen recognition through the
cytoplasmic association of CD4 with the lymphocyte
kinase Lck. In the case of CD4, the receptor–receptor
interaction is induced by the association with a T cell and
not through binding of a soluble, secreted molecule.
In contrast, several structures of the typically tight binding
complexes between members of the cytokine receptor
superfamily and their natural ligands have been deter-
mined. The human GH receptor complex, in which two
extracellular receptor fragments interact asymmetrically
with the GH ligand, was the first crystal structure of a
cytokine receptor complex [5]. Similar studies have now
provided detailed structural information on a number of
such systems and have illustrated considerable structural
variety in the receptor–ligand interactions [6–12]. Of most
relevance to this study, the crystal structure of a 2:1
complex between soluble non-glycosylated human
IFN-γRα (sIFN-γRα) and IFN-γ with two receptor mol-
ecules bound to the dimeric ligand has been reported by
Walter et al. [7] and, more recently, a 1:1 crystal structure of
human sIFN-γRα bound to a mutant monomeric form of
IFN-γ [13] (AA Kossiakoff, personal communication) has
been determined. Except for one of the interleukin-1 struc-
tures [11] where the first carbohydrate units at the glycosy-
lation sites were observed in the electron-density maps,
none of these receptor fragments were expressed with gly-
cosylation, and virtually no structural data exist regarding
the role of glycosylation in these receptor complexes.
Here, we report a crystal structure containing a complex of
two glycosylated sIFN-γRα molecules and one non-glyco-
sylated IFN-γ∆10 dimer plus a third unexpected glyco-
sylated sIFN-γRα molecule. The notation ∆10 indicates a
ten-residue deletion of the C terminus of each monomer,
hereafter referred to as IFN-γ. The C-terminal truncation
slightly enhances receptor affinity [14]. In this crystal
structure, the IFN-γ dimer binds two of the glycosylated
sIFN-γRα molecules, as previously reported for the 2:1
non-glycosylated complex [7]. The third sIFN-γRα mol-
ecule makes two distinct contacts with the receptor chains
of the 2:1 complex. Previous studies have demonstrated
multisubunit complex formation between IFN-γ and the
two receptor chains, Rα and Rβ, both in solution and at
the cell surface [2]. These studies suggest that the 2:1
sIFN-γRα–IFN-γ complex associates with two chains of
the IFN-γRβ receptor. Because of the significant struc-
tural similarity between the Rα and Rβ proteins [15], the
receptor–receptor interactions reported here have been
examined as models of how the IFN-γRβ receptor might
associate with the 2:1 complex to form the activated
complex necessary for signaling. 
Results and discussion
Structure determination by MAD phasing 
Crystals of the sIFN-γRα–IFN-γ complex were variable in
quality and rarely diffracted beyond 3.8 Å [16]. In addition,
attempts to produce heavy-atom derivatives were unsuc-
cessful. Therefore, conventional heavy-atom methods for
structure determination were abandoned and multiwave-
length anomalous diffraction (MAD) phasing was used.
Selenium incorporation into the complex was accom-
plished by substituting the methionine residues of only the
IFN-γ dimer with selenomethionine (SeMet) and binding
this SeMet-substituted IFN-γ to the unsubstituted, glyco-
sylated sIFN-γRα [16]. Compared to human IFN-γ,
Escherichia coli-derived IFN-γ contains an extra methionine
at the N terminus of each monomer, which was found to be
disordered in the complex. Hence, phase determination for
the 120 kDa complex utilized only six selenium sites.
The crystal structure was determined by MAD phasing
using 3.8 Å data merged from four SeMet crystals and
extended to 2.9 Å using native data from one crystal. Syn-
chrotron radiation and charge-coupled device (CCD)-
based X-ray detectors were utilized for all data collection.
The structure was refined to an R factor of 23.7%
(Rfree = 30.2%) using diffraction data from 6.0 Å to 2.9 Å.
Results of the refinement are shown in Table 1; the final
model has good stereochemistry. The Ramachandran plot
shows none of the amino acid residues of the IFN-γ in the
disallowed regions and only one sIFN-γRα residue,
Val206, in the disallowed region for all three receptors.
The structure determination of this sIFN-γRα–IFN-γ
complex demonstrates the capability of the MAD phasing
technique applied to large macromolecular assemblies,
even when the anomalous signal is weak. Although the
quality of the crystals was poor, resulting in very weak
diffraction, the 120 kDa complex is one of the largest
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structures determined by MAD phasing [17]. In addition,
the phasing utilized only six selenium atom positions,
which required extraction of a very weak anomalous signal
(1 selenium/144 residues or 20 kDa/selenium atom). The
large MAD structures reported to-date have utilized con-
siderably stronger phasing signals, typically corresponding
to 1.6 to 5.6 kDa per selenium atom [17].
In addition, the approach used here allowed the MAD
analysis of a mixed complex in which one component was
expressed in E. coli and contained selenium atoms, whereas
the other component was glycosylated. This method of
selenium incorporation may be particularly useful when
different expression systems are required to produce the
different components of a macromolecular assembly.
Finally, the experiment utilized a protein of known struc-
ture containing selenium-substituted residues thereby
allowing the use of molecular replacement methods to
locate the selenium positions when the anomalous signal
was weak. Critical to the success of this project was the
combined use of efficient and sensitive CCD-based X-ray
detectors, an intense, tunable synchrotron source and cry-
oprotection of the radiation-sensitive crystals.
Description of the overall structure
The asymmetric unit of the crystals contains three glycosy-
lated IFN-γRα fragments, each consisting of the first 245
residues of the extracellular domain minus the 17-residue-
long signal domain, and one non-glycosylated IFN-γ
dimer, of which each IFN-γ chain consists of the first 133
residues plus an extra N-terminal methionine (Figure 1).
Two of the glycosylated sIFN-γRα molecules (R1 and R2)
are symmetrically bound to the IFN-γ dimer in the same
way as previously reported for the 2:1 non-glycosylated
receptor–ligand complex [7]. The two bound receptor
chains do not interact, their closest distance being 30 Å.
The third receptor molecule, R3, makes contacts with
both R1 and R2, but not with IFN-γ. In principle, either of
the two equivalent R3 molecules can be chosen to define a
3:1 complex. In either case the interactions involve primar-
ily the C-terminal receptor domains. We have chosen the
3:1 complex involving R1–R3 interactions because it is
more compact than the one involving R2–R3 interactions.
The presence of the third receptor domain was unex-
pected as the material used for crystallization had been
purified and well characterized as a 2:1 complex [18].
Sodium dodecyl sulfate polyacrylamide gel electrophore-
sis (SDS–PAGE) of washed, redissolved crystals showed
only intact ligand and receptor molecules (data not
shown), but their relative amounts were not quantified.
We can only speculate that during crystal growth, and
perhaps favored by the specific crystallization conditions,
partial dissociation of 2:1 complexes can take place to the
extent needed for incorporation of an extra receptor mol-
ecule into the crystal lattice.
Structure of the IFN-γ homodimer
The IFN-γ homodimer is composed of two monomers (I1
and I2) that contain six α helices each. Four of the helices
of one monomer are interdigitated with two of the helices
of the other monomer thereby forming a globular structure
with a noncrystallographic twofold axis. All 12 helices run
approximately parallel to the local twofold axis. Both the
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Table 1
Crystal data and refinement statistics.
Space group C2
Cell dimensions
a, b, c (Å) 199.3, 114.6, 74.3
β (°) 116.27
Z 4
Protein fraction (%) 39
Vm (Å3/Da) 3.17
Total number of residues 862
Total nonhydrogen atoms 6914
Average temperature factors (Å2)
IFN-γ 44.5
IFN-γRα
D1 of R1 58.7
D2 of R1 55.6
D1 of R2 58.0
D2 of R2 60.8
D1 of R3 115.3
D2 of R3 62.1
Resolution range of reflections used (Å) 6.0–2.9
Amplitude cutoff None
R factor (%) 23.7
Free R factor (%) 30.2
Stereochemical ideality
bonds (Å) 0.014 
angles (°) 2.29
impropers (°) 1.93
Figure 1
Ribbon diagram of the 3:1 sIFN-γRα–IFN-γ complex. The complex is
formed by combining the 2:1 complex with receptor R3. The IFN-γ
dimer (I1 and I2) is shown in yellow; the R1 receptor is in red, the R2
receptor in blue, and the R3 receptor in green. The complex is oriented
such that the normal axis to the cell membrane is approximately vertical. 
C-terminal tails are poorly ordered after residue 120. Weak
continuous density is seen up to about residue 126 in both
ligand chains but the structural model fitted to this
density has very large refined B factors.
The α-helical IFN-γ structure is similar to that previously
reported for both the free and bound forms [7,19]. The
two IFN-γ monomers present in our structure are nearly
identical. The largest differences are observed at the N
and C termini; however, these regions are affected by high
thermal parameters and structural disorder. The bound
IFN-γ monomers differ most significantly from those of
the free dimer in one loop region (residues 16–27) with
deviations as large as 7.7 Å observed at residue 23. In the
free form, this loop is somewhat disordered [19], but in the
complex it becomes well ordered through the extensive
interactions with the receptor, giving rise to the formation
of a 310 helix at residues 20–23 as previously described for
the non-glycosylated 2:1 complex [7].
Structure of the glycosylated sIFN-γRα
The glycosylated sIFN-γRα molecule consists of two
immunoglobulin-like β-sheet domains (D1 and D2 for
the N- and C-terminal domains, respectively) each with
fibronectin type-III topology (Figure 2a). The D1 and D2
domains are connected by a short, flexible linker. The D1
domain, composed of residues 14–102, forms a β sandwich
with three β strands stacked on a layer of four β strands.
The D2 domain, composed of residues 114–221, also
forms a β sandwich; in this case both β sheets consist of
four β strands. The 11-residue-long linker domain (residues
103–113) contains a six-residue helix that is also observed
in human tissue factor [20].
In the final model, the two ligand-binding receptors R1
and R2 have residues missing in the loop connecting
strands B and C of the D2 domain and at their disordered
N and C termini.
Conformational variability of residues 131–139 of the BC
loop has also been observed in the previously reported 2:1
complex [7]. The D2 domain of the third receptor, R3, is
clearly visible in the electron-density maps. However, the
entire D1 domain of R3 is highly disordered and only
weak, non-contiguous electron density, consistent with
the specific fold of D1, was observed in this region. The
high degree of disorder observed for this domain is consis-
tent with the observation that D1 of R3 is not involved in
any intermolecular contacts in the crystal. Consequently,
no conclusions have been drawn regarding the functional
and structural roles of individual amino acid residues
within the D1 domain of R3.
The structure of the glycosylated sIFN-γRα molecule
reported here appears to be very similar to that of the
molecule expressed without glycosylation, which has been
described in detail [7]. However, detailed comparisons are
not possible because the coordinates of the 2:1 non-glyco-
sylated complex are unavailable. Within the 3:1 complex
reported here, superposition of the D2 domains of the
three crystallographically independent receptor chains
shows that the relative orientations of domains D1 and D2
are nearly identical for R1 and R2, but appears quite dif-
ferent for R3 (Figure 2b). The hinge angle between D1
and D2 is ~120° for R1 and R2 but reduces to 110° for R3.
Without such a change in the hinge angle, D1 of R3 would
collide with neighboring molecules in the crystal. Neither
the two D1 domains of R1 and R2 (that of R3 was treated
as a rigid body) nor the three D2 domains show significant
structural variation in this 2.9 Å structure, owing, in part,
to the noncrystallographic symmetry restraints that were
applied during refinement. Through inspection of differ-
ence maps, significant structural differences were indi-
cated in the region of residues 164–170 and 218–220 and
the restraints were correspondingly relaxed. The largest
deviations are seen in poorly ordered loop regions, where
some B factors are greater than 75 Å2.
Glycosylation sites of sIFN-γRα
Each of the sIFN-γRα molecules contains four glycosyla-
tion sites, residues 17, 62, 69 and 162, all of which are
asparagines. A fifth potential glycosylation site, Asn223, was
shown to be unpopulated in the expression system used
here [21]. The electron density of the sIFN-γRα–IFN-γ
complex shows carbohydrate density at each of the four
residues within R1 and R2. For the more disordered R3,
only the glycosylation site of the D2 domain, Asn162, shows
clear electron density. The electron density at these glyco-
sylation sites typically extends for ~10 Å beyond the
asparagine residues. The density at each site is weak rela-
tive to the protein density and forms a branching network,
thus preventing detailed modeling. The density of the gly-
cosylation site of Asn62 of R2 is shown in Figure 3. Glyco-
sylation does not appear to be involved in either the
receptor–ligand interactions or in any crystal contacts.
Receptor–ligand interactions
The 2:1 receptor–ligand complex has approximate twofold
symmetry, and it is reasonable to assume that the mem-
brane-inserted complex containing the full-length receptor
would have this twofold axis oriented perpendicular to the
membrane with the C terminus of the truncated receptor
chains close to the membrane (see Figure 1). Each of these
receptor chains forms a contiguous interface with the IFN-γ
dimer, involving segments from both domains of the
ligand. A detailed description of the receptor–ligand inter-
actions for the previously reported structure determination
of the 2:1 complex containing non-glycosylated sIFN-γRα
molecules has been presented [7].
Overall, the interactions described by Walter et al. [7] are
quite similar to those observed here, but as coordinates are
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not available no detailed comparison can be presented.
The putative hydrogen-bonding interactions observed in
the interface of our structure are listed in Table 2. Seven
of the listed putative interactions, highlighted in bold,
were not reported in the previous structure determination
[7]. Mainchain hydrogen-bond interactions contribute sig-
nificantly to the binding interface, and in both structures
the receptor–ligand interactions appear highly symmetri-
cal. One difference is the mainchain conformation at
Gly18–His19, which in I2 leads to the formation of a
hydrogen bond to the receptor Trp82 sidechain as in
Walter et al. [7], while in I1 this peptide plane is rotated by
~90°. Closer examination of their stereochemistry and
environment in both interfaces shows that the salt-bridge
interaction of Lys12 with Glu101 and the Lys108–Tyr49
hydrogen bond nicely complement the previously
reported interactions of the buried Glu101 and Tyr49
receptor sidechains. The Ala118–His205 hydrogen bond
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Figure 2
Structure of sIFN-γRα. (a) Stereoview Cα
trace for sIFN-γRα with every tenth residue
labeled. (b) Superposition of the three
sIFN-γRα molecules. The superposition of the
receptor molecules is based on the D2 domain
only. Variations of the hinge angle between the
D1 and D2 domains of each receptor is
shown. The R1 receptor is in red, the R2
receptor in blue, and the R3 receptor in green. 
also shows good stereochemistry in both interfaces. The
remaining four newly reported interactions (Glu9–Trp207,
Ser20–Lys98, Asp24–Ser54, Asn25–Asn53) suffer from
unfavorable stereochemistry.
Studies with C-terminally truncated IFN-γ variants have
shown that in the C terminus, in particular, the highly
basic segment Lys128–Arg129–Lys130–Arg131 con-
tributes significantly to binding [22,23]. However, it has
remained controversial whether this is due to specific
ligand–receptor interactions or to other structural effects
[24]. No interactions were reported beyond residue 115 of
IFN-γ in the 2:1 complex and the authors suggested that a
plausible interaction with an acidic cluster on the receptor
chain might have been prevented by crystal contacts [7].
In our structure, the electron density is weak beyond
residue 120 of IFN-γ and the twofold symmetry is no
longer preserved. Although models were built and refined
up to residue 126, they are not reliable for this segment, as
indicated by very high thermal parameters. The modeled
conformations with the Lys125 sidechains interacting with
Glu173 and/or Glu175 for I1 and with Glu180 for I2 at
best represent partially populated conformational states.
However, the interactions with the acidic cluster on the
receptor chains are not hindered by crystal contacts. It
appears that the contribution of the C-terminal tails to
receptor binding is not through a structurally defined,
specific interface. It cannot be ruled out, however, that
nonspecific interactions between the basic and acidic clus-
ters on IFN-γ and its receptor, respectively, involving
multiple conformational states, account for the observed
binding contribution of the C terminus.
Receptor–receptor interactions in the crystal packing
Crystals of the glycosylated complex generally displayed
anisotropic diffraction falling off in the direction corre-
sponding to the c axis. Examination of the crystal contacts
reveals that the third receptor molecule R3 plays an impor-
tant role in mediating intermolecular contacts along this
axis. In the current structure (Figure 4), the D2 domains of
the symmetry-related R2 receptor chains form crystal-
packing contacts. The R1 molecules are not linked to each
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Figure 3
Electron density in the region of expected glycosylation. The final
2Fo–Fc map, contoured at 1.2σ, shows weak glycosylation density
branching from Asn62 of the R2 receptor. Other potential
glycosylation sites show similar electron density.
Table 2
Potential hydrogen-bond and salt-bridge interactions between
the IFN-γ dimer and the sIFN-γRα molecules.
IFN-γ sIFN-γRα Distance (Å)
I1 Gln1 Nε2 R1 Trp207 O 2.6
I1 Glu9 Oε1 R1 Arg106 Nε 3.4
I1 Glu9 Oε1 R1 Trp207 Nε1 3.0
I1 Lys12 Nζ R1 Glu101 Oε1 2.9
I1 Ser20 OH R1 Lys98 Nz 3.2
I1 Ala23 O R1 Gly50 N 3.3
I1 Ala23 O R1 Val51 N 3.0
I1 Asp24 Oδ1 R1 Lys47 Nζ 2.6
I1 Asp24 Oδ1 R1 Ser54 OH 2.8
I1 Asn25 N R1 Val51 O 3.3
I1 Asn25 N R1 Asn53 O 2.8
I1 Gly26 N R1 Val51 O 2.6
I1 Lys108 Nζ R2 Tyr49 OH 2.9
I1 His111 Nε2 R2 Glu101 Oε1 2.8
I1 Glu112 Oε2 R2 Tyr49 OH 2.9
I1 Gln115 Nε2 R2 Asn79 Oδ1 2.9
I1 Ala118 O R2 His205 Nε2 3.0
I2 Gln1 Nε2 R2 Trp207 O 3.2
I2 Glu9 Oε1 R2 Arg106 Nε 3.2
I2 Glu9 Oε1 R2 Trp207 Nε1 3.5
I2 Lys12 Nζ R2 Glu101 Oε1 3.0
I2 Gly18 O R2 Trp82 Nε1 3.0
I2 Ser20 OH R2 Lys98 Nζ 3.0
I2 Ala23 O R2 Gly50 N 3.1
I2 Ala23 O R2 Val51 N 2.7
I2 Asp24 Oδ1 R2 Lys47 Nz 2.9
I1 Asp24 Oδ1 R2 Ser54 OH 2.8
I2 Asn25 N R2 Val51 O 2.8
I2 Asn25 N R2 Asn53 O 2.9
I2 Gly26 N R2 Val51 O 2.6
I2 Lys108 Nζ R1 Tyr49 OH 3.2
I2 His111 Nε2 R1 Glu101 Oε1 2.9
I2 Glu112 Oε2 R1 Tyr49 OH 2.8
I2 Gln115 Nε2 R1 Asn79 Oδ1 2.7
I2 Ala118 O R1 His205 Nε2 3.3
Because of the resolution of the diffraction data and the error within the
final structure, probable interactions separated by as much as 3.8 Å are
listed. Interactions involving the C termini of the IFN-γ chains where B
factors of the mainchain atoms exceed 100 Å2 have been excluded.
Those interactions not reported in Walter et al. [7] are in bold type.
other through crystal-packing contacts. Instead, the D2
domain of R1 and a symmetry-related D2 domain of R2
are bridged by the D2 domain of R3 (Figure 4a). The con-
tacts along c are thus mediated by three distinct interfaces,
each of which involves two D2 receptor domains (R2/R2′,
R3/R1 and R3/R2). Moreover, all three contacts involve β
strand C′ from at least one of the D2 domains. These
interactions are listed in Table 3. Two of the β-strand
interactions are antiparallel (R2–R2′ and R3–R2) whereas
the third is parallel (R3–R1). The antiparallel R2–R2′
interaction between two symmetry-related C′ strands
involves four hydrogen bonds between mainchain atoms
and four hydrogen bonds between sidechain atoms. The
antiparallel R3–R2 interaction is between strand C′ on R3
and strands A and G on R2. Two hydrogen bonds between
mainchain atoms and three more potential hydrogen bonds
involving sidechain atoms are observed. The parallel
R3–R1 interaction is between strands A and G on R3 and
strand C′ on R1. Four mainchain hydrogen bonds, three
hydrogen bonds involving sidechain atoms and one salt
bridge are observed in this interface.
We have examined a number of crystal structures contain-
ing structurally homologous cytokine receptors for the
occurrence of similar interdomain contacts. We could not
find any additional examples of receptor molecules that
are involved in analogous interactions.
The observed receptor–receptor interactions may reflect
the tendency for receptor domains to associate and has
prompted us to examine whether such interactions could
mimic the association of the 2:1 complex with the struc-
turally homologous Rβ chain [15]. Ternary complex for-
mation of IFN-γ with the Rα and Rβ receptors has been
shown to occur on the cell surface and, using truncated
extracellular receptor domains, also in solution [2].
Although it has not been demonstrated experimentally,
we consider it probable that Rβ interacts with both IFN-γ
and Rα in the ternary complex. No binding of Rβ to either
Rα or IFN-γ alone has been reported and the individual,
putative interfaces most probably provide only little
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Figure 4
Crystal contacts involving D2 receptor domains. (a) Receptor R3 is
shown in green bridging receptor R1 (red) and a symmetry-related
receptor R2′ (magenta). (b) Receptor R2 is shown in blue and an R2
receptor related by twofold symmetry (R2′) is shown in magenta.
These interactions form the primary packing contacts in the crystals of
the complex.
Table 3
Potential hydrogen-bond and salt-bridge interactions in
receptor–receptor contacts. 
Interaction Distance (Å)
Parallel strand interaction between R1 and R3
R1 R3
Glu165 O Glu216 N 3.8
Gln167 N Glu216 O 3.1
Gln167 O Cys218 N 3.3
Tyr168 OH Gln195 Oδ1 3.3
Lys169 Nζ Asp116 Oδ1 2.9
Lys169 N Cys218 O 3.5
Lys174 Nζ Lys119 O 2.6
Ala186 O Gln195 Nε2 3.1
Antiparallel strand interaction between R3 and R2
R3 R2′
Gly163 O Lys119 Nζ 3.8
Glu165 O Thr220 N 2.5
Gln167 N Cys218 O 3.8
Tyr168 OH Asp116 Oδ1 3.8
Ser191 Oγ Lys119 O 2.4
Antiparallel strand interaction between R2 and R2′
R2 R2′
Glu165 Oε1 Lys169 Nζ 3.3
Glu165 O Lys169 N 3.6
Gln167 N Gln167 O 3.3
Gln167 Oε1 Gln167 Nε2 3.4
Gln167 Nε2 Gln167 Oε1 3.4
Gln167 O Gln167 N 3.3
Lys169 N Glu165 O 3.6
Lys169 Nζ Glu165 Oε1 3.3
Because of the resolution of the diffraction data and the error within
the final structure, likely interactions separated by as much as 3.8 Å
are listed.
binding energy. Furthermore, the location of the ternary
complex on the cell surface produces topological con-
straints for plausible ternary complex structures. In partic-
ular, the C termini of the associated Rα and Rβ receptor
chains should be close to a plane located on one side of
the complex and approximately perpendicular to the
twofold axis of the 2:1 complex (Figure 1). Only one of the
three observed Rα–Rα interactions, the parallel strand
interaction R3–R1, is compatible with this constraint.
Interestingly, the D1 domain of R3 is positioned such that
interactions of the third receptor with the cytokine ligand
appear possible. Figure 5 shows the atomic interactions
that form the parallel β-sheet interaction between R1 and
R3 resulting in the 3:1 complex shown in Figure 1.
The 3:1 complex suggests a structural model that may
provide insight into the formation of the ternary complex
in the IFN-γ signaling pathway. Although the third recep-
tor may be only an artifact of crystallization, it is neverthe-
less interesting to speculate about the implications for
association of the Rα and Rβ chains with the IFN-γ
ligand. Because the Rα and Rβ chains showed significant
homology, we believe that the Rα chain is a reasonable
model for Rβ [2,3]. In modeling the ternary complex, the
positioning of the third Rα chain in this 3:1 complex
reveals that only the domain 2 region of the third receptor
could make contact with the IFN-γ ligand. In particular,
the region between the end of strand C′ and the begin-
ning of strand E, which is likely to assume a somewhat dif-
ferent structure in Rβ, lies close to the N terminus and to
helix D of IFN-γ. In addition, the model could accommo-
date an additional twofold-related Rβ giving an overall
stoichiometry of 2:2:1. Although addition of this final Rβ
molecule is prevented by crystal packing, it could be
easily accommodated in the isolated IFN receptor
complex. In fact, it is difficult to imagine other ways that a
symmetric 2:2:1 complex, in which receptors interact
through their C-terminal domains, could be formed. Obvi-
ously this model is very speculative and an experimentally
determined structure of the ternary complex of IFN-γ, Rα
and Rβ is required to determine the detailed interactions.
Nevertheless, our model makes some clear predictions
that could be tested by further experimentation.
Biological implications 
Protein–protein interactions are ubiquitous in the biology
of the cell. Here, we report new interactions in the 3:1
complex of the soluble portion of the high-affinity inter-
feron-γ (IFN-γ) receptor bound to IFN-γ. The associa-
tion of these two proteins is known to be the first step in
the signaling pathway of the cell-secreted cytokine IFN-γ.
For these studies, glycosylation was maintained on the
receptor fragments. X-ray crystallography reveals the
receptor–ligand association previously observed in a 2:1
non-glycosylated complex [7], but with a third receptor
molecule present. Interactions involving the third recep-
tor consist of contacts between β strands of the C-termi-
nal domains of the receptor fragments. We believe the
association of a third high-affinity receptor within the 3:1
complex suggests a model for higher order oligomeriza-
tion. In particular, the binding of the third receptor may
mimic the interaction of the accessory factor protein
known to be required in the formation of the active IFN-γ
signaling complex. It may also serve as a model for
other cytokine signaling pathways for which receptor
oligomerization occurs. The structure of the 3:1 complex
reveals additional interactions within the receptor–ligand
interface, thereby leading to a more complete description
of this protein–protein interaction. Although glycosyla-
tion is evident in the crystal structure, it does not
appear to be directly involved in any of the observed
protein–protein interactions.
Materials and methods
Protein purification and crystallization 
The extracellular domain (the 245 N-terminal residues minus the 17-
residue-long N terminus signal domain) of the IFN-γRα chain was
expressed in baculovirus-infected SF9 insect cells and was heteroge-
neously glycosylated. The molecular weight of the purified receptor
fragment is 29 kDa, of which ~6 kDa are the carbohydrate moieties
[18]. Human IFN-γ∆10 (lacking ten C-terminal residues) was expressed
in E. coli and purified as a 32 kDa dimer as previously described [14].
In addition, SeMet-substituted IFN-γ was prepared for the MAD
phasing experiment using an E. coli strain that is auxotrophic for
methionine [14]. An extra methionine is present at the N terminus of
each monomer in E. coli-derived IFN-γ. The receptor–ligand complex of
the native IFN-γ was formed and characterized by chemical cross-
linking, chromatography, analytical centrifugation and laser-light scat-
tering [25]. These results suggest that two sIFN-γRα were bound to
each IFN-γ dimer. Similar procedures were followed in the formation of
the complex containing SeMet IFN-γ. The SeMet complex contained
eight SeMet residues.
Native and SeMet complexes were crystallized in a pH 7.0 solution con-
taining 12.5% PEG 8000 and Tris buffer by the hanging-drop method
as previously described [16]. The native and the SeMet-incorporated
complexes behaved similarly and crystallized in the monoclinic space
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Figure 5
The R3–R1 parallel β-sheet interface. The portion of the interface
consisting of R1 residues is shown in red and that of R3 is in green.
Key residues are labeled.
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group, C2, resulting in small plate-like crystals. The sIFN-γRα–IFN-γ
crystals diffract weakly with mosaic spreads in excess of 1° and exhib-
ited severe radiation damage. The unit-cell dimensions of the native
crystal form were a = 199.30 Å, b = 114.65 Å, c = 74.34 Å, and
β = 116.27°, while those of the SeMet-incorporated complex were
a = 201.51 Å, b = 113.90 Å, c = 74.10 Å, and β = 117.04°. The crystals
contain one 120 kDa complex in the asymmetric unit resulting in 61%
solvent content. 
X-ray data collection 
The MAD data were collected at the Cornell High Energy Synchrotron
Source (CHESS) using station F2 and a 1k × 1k CCD-based X-ray
detector, with an active area of 52 mm × 52 mm [26]. Data were col-
lected at four X-ray wavelengths near the Se K-edge corresponding to
the most negative value of f′ (λ1 = 0.9795 Å), the maximum value of f′′
(λ2 = 0.9793 Å), intermediate values of f′ and f′′ (λ3 = 0.9790 Å), and a
remote reference wavelength (λ4 = 0.9642 Å). The Bijvoet pairs were
measured using inverse-beam geometry. The intensity of the F2 beam
was low because of monochromator heating, resulting in long exposure
times of 5–10 min per 2° oscillation. In addition to being unusually weak,
the diffraction from these crystals was highly anisotropic and extended
to only 3.8 Å resolution for the SeMet complex. Even with liquid-nitro-
gen-cooling, the crystals were radiation-sensitive and four crystals were
required to obtain a complete MAD data set. The data from each crystal
were processed independently using the computer program DENZO
[27]. Merging and scaling was compromised by lack of overlap among
the four different crystals. Using the native data set described below,
each MAD data set was brought to a common scale with anisotropic
scaling using the program SCALEIT [28]. The combined MAD data was
75% complete to 3.8 Å resolution. The data collection and processing
statistics for the four Se-Met crystals are given in Table 4.
Higher resolution diffraction was observed from native IFN-γRα–IFN-γ
crystals using the high intensity A-1 wiggler stations at CHESS. A data
set extending to 2.7 Å was measured (λ = 0.919 Å) using a 2k × 2k
CCD-based X-ray detector with an active area of a 82 mm × 82 mm
[29] and a single flash-cooled native crystal. Diffraction from this crystal
was isotropic and stronger than the crystals used for MAD data, result-
ing in exposure times of 60 s per 1° oscillation. The native crystal had a
mosaicity of approximately 1°. The native data were processed using
the computer program DENZO [27]. The data collection and process-
ing statistics for the native crystal are given in Table 4.
Structure determination
Initial attempts to determine the positions of the selenium atoms from
the inspection of the Patterson map were unsuccessful. Therefore, the
previously determined unbound IFN-γ dimer structure [19] was ori-
ented and positioned in the crystal coordinate system using the mol-
ecular replacement program AMoRe [29]. Phases were calculated
from the IFN-γ model (27% of the total asymmetric unit) and model bias
was removed using SIGMAA [29]. A difference Fourier map was calcu-
lated using the weighted molecular replacement phases and the coeffi-
cients corresponding to SeMet-incorporated complex data minus the
native data. The top four peaks corresponded to known methionine
residues of the IFN-γ, with two of these peaks falling in the region of
each IFN-γ monomer where two neighboring methionines are difficult to
distinguish from each other at this resolution. Therefore, the six sulfur
sites of the native IFN-γ were used as initial estimates of the selenium
atom positions for subsequent MAD phasing. The two N-terminal
methionines unique to the E. coli-derived IFN-γ appeared to be disor-
dered. The six selenium atom positions were used to calculate phases
using the program MLPHARE [29]. The initial 3.8 Å map showed the
boundary of the complex and some features of the IFN-γ and the IFN-γ-
bound sIFN-γRα molecules.
Phases were improved and extended to 2.7 Å using solvent-flattening,
noncrystallographic symmetry (NCS) averaging, histogram matching
and the program DM [29]. The resulting map allowed the building of
partial models for the two ligand-bound sIFN-γRα molecules. The
model, consisting of the IFN-γ dimer and the two sIFN-γRα chains, was
initially refined against the diffraction data between 8.0 Å and 2.9 Å
using the positional refinement of X-PLOR [30]. A randomly chosen set
of 5% of the reflections were reserved for calculating the Rfree value
that was used as a guide throughout the refinement process. As the
model was being built, three NCS operations were independently
defined for I1 and I2, the D1 domains of R1 and R2, and the D2
domains of R1 and R2. The orientation matrix for each of these
domains differed slightly. Updated solvent-flattening and averaging
masks were frequently created as the model progressed.
After several iterative cycles of density modification and phase combi-
nation followed by further model building and positional refinement, an
additional β-sheet domain became apparent in the electron-density maps.
This surprising finding gave the first suggestion that a third sIFN-γRα
molecule was present in the complex. Model building of the unexpected
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Table 4
Statistics of the X-ray diffraction data.
Crystal Exposure time Resolution Wavelength Measured Unique Completeness Rsym* Riso†
(s) (Å) (Å) reflections reflections (%)
1 300 20–3.8 0.9795 28,459 9919 34.3 0.059 0.216
0.9793 28,473 9866 34.1 0.060 0.216
0.9790 28,524 9896 34.2 0.060 0.216
0.9642 28,444 9815 33.9 0.058 0.217
2 450–600 20–3.8 0.9795 40,128 11,043 38.2 0.074 0.275
0.9793 40,198 11,063 38.2 0.074 0.273
0.9790 40,150 11,031 38.1 0.076 0.275
0.9642 40,087 11,070 38.3 0.076 0.276
3 600 20–4.0 0.9795 32,468 6366 25.7 0.092 0.251
0.9793 32,525 6347 25.6 0.098 0.249
0.9790 32,534 6392 25.8 0.093 0.252
0.9642 32,034 6229 25.1 0.091 0.254
4 300–600 20–3.8 0.9795 38,768 9508 32.9 0.066 0.281
0.9793 38,774 9516 32.9 0.067 0.282
0.9790 38,804 9482 32.8 0.068 0.282
0.9642 38,861 9457 32.7 0.067 0.286
Native 60 45–2.7 0.910 176,010 33,105 80.1 0.056 –
*Rsym = Σhkl Σi|Ihkl, i – <I>hkl| / Σ| <I>hkl|. †Riso = Σ | FPH – FP | / Σ FP.
electron-density domain produced a seven-stranded β-sheet sand-
wich structure. The identity of the region was determined crystallo-
graphically by aligning the modeled domain with the D1 and D2
domains of the two sIFN-γRα molecules. A high correlation was found
with a particular orientation of one of the D2 domains. This alignment
was then compared to the density-modified Fo map and striking
agreement was found in the location of the disulfide bridges and
various hydrophobic residues thereby confirming the assignment of
the domain as a sIFN-γRα D2 domain. 
Attempts to define the D1 domain of R3 were less convincing. A fourth
NCS operation was defined relating the D2 domains of R2 and R3 in
the final application of density modification. Also, a new protein mask
was prepared for the entire complex by using the well defined D2
domain of R3 and an intact sIFN-γRα molecule to define the mask for
D1 of R3. The calculated phases based on the existing model (not
including D1 of R3) were combined with the MAD phases and the
processes of solvent-flattening, histogram mapping and symmetry-aver-
aging were again carried out. The resulting phases produced a map
that suggested the placement of the D1 domain. The electron density
in this region of the map, however, was not continuous. The D1 domain
for R3 was positioned as a rigid body resulting in no bad contacts.
Several additional rounds of model adjustment and NCS-restrained
positional refinement were conducted in which the atoms of the D1
domain of R3 were treated as a rigid body. The NCS restraints for spe-
cific residues were relaxed as the difference maps produced convinc-
ing indications that these residues with differing molecular contacts
should have positional variations. Bulk-solvent modeling was not
included because, on the basis of the Rfree parameter, it failed to
improve the refinement. Instead, somewhat lower Rfree values were
obtained when the model was refined against the data with a low-reso-
lution cutoff of 6 Å rather than 8 Å. This was substantiated by control
calculations in which R factors were calculated to only 6 Å for models
refined against data extending to 8 Å. The results of the refinement are
summarized in Table 1.
Accession numbers 
The atomic coordinates have been deposited in the Protein Data Bank,
operated by the Research Collaboratory for Structural Bioinformatics,
with accession code 1FG9. 
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